290 related articles for article (PubMed ID: 34404562)
1. Disorders of Fibrinogen and Fibrinolysis.
May JE; Wolberg AS; Lim MY
Hematol Oncol Clin North Am; 2021 Dec; 35(6):1197-1217. PubMed ID: 34404562
[TBL] [Abstract][Full Text] [Related]
2. Genetic Variants in the
Simurda T; Brunclikova M; Asselta R; Caccia S; Zolkova J; Kolkova Z; Loderer D; Skornova I; Hudecek J; Lasabova Z; Stasko J; Kubisz P
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610551
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis and the control of blood coagulation.
Chapin JC; Hajjar KA
Blood Rev; 2015 Jan; 29(1):17-24. PubMed ID: 25294122
[TBL] [Abstract][Full Text] [Related]
4. Physiological correction of hereditary mild hypofibrinogenemia during pregnancy.
Marchi R; Durual S; Pecheux O; Neerman-Arbez M; Casini A
Haemophilia; 2023 May; 29(3):836-843. PubMed ID: 36757142
[TBL] [Abstract][Full Text] [Related]
5. Blood clot contraction differentially modulates internal and external fibrinolysis.
Tutwiler V; Peshkova AD; Le Minh G; Zaitsev S; Litvinov RI; Cines DB; Weisel JW
J Thromb Haemost; 2019 Feb; 17(2):361-370. PubMed ID: 30582674
[TBL] [Abstract][Full Text] [Related]
6. THE INFLUENCE OF FIBRINOGENOLYTIC AND FIBRINOLYTIC SPLIT PRODUCTS ON THE LAST STAGE OF COAGULATION.
GODAL HC; HELLE I
Scand J Clin Lab Invest; 1963; 15():327-30. PubMed ID: 14073280
[No Abstract] [Full Text] [Related]
7. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of α1 -antitrypsin in fibrin clots.
Talens S; Malfliet JJ; van Hal PT; Leebeek FW; Rijken DC
J Thromb Haemost; 2013 Jul; 11(7):1319-28. PubMed ID: 23648095
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen BOE II: dysfibrinogenemia with bleeding and defective thrombin binding.
Li Y; Liang Q; Wu W; Hu X; Wang H; Wang X; Ding Q
Res Pract Thromb Haemost; 2023 Jul; 7(5):102145. PubMed ID: 37601017
[TBL] [Abstract][Full Text] [Related]
10. Congenital Afibrinogenemia and Hypofibrinogenemia: Laboratory and Genetic Testing in Rare Bleeding Disorders with Life-Threatening Clinical Manifestations and Challenging Management.
Simurda T; Asselta R; Zolkova J; Brunclikova M; Dobrotova M; Kolkova Z; Loderer D; Skornova I; Hudecek J; Lasabova Z; Stasko J; Kubisz P
Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829490
[TBL] [Abstract][Full Text] [Related]
11. Etiology and management of hypofibrinogenemia in trauma.
Nathwani R; Proumen A; Blaine KP
Curr Opin Anaesthesiol; 2023 Jun; 36(3):382-387. PubMed ID: 36994749
[TBL] [Abstract][Full Text] [Related]
12. Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges.
Gaule TG; Ajjan RA
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203139
[TBL] [Abstract][Full Text] [Related]
13. Impact of Fibrinogen Infusion on Thrombin Generation and Fibrin Clot Structure in Patients with Inherited Afibrinogenemia.
Khayat C; Marchi R; Durual S; Lecompte T; Neerman-Arbez M; Casini A
Thromb Haemost; 2022 Sep; 122(9):1461-1468. PubMed ID: 35045578
[TBL] [Abstract][Full Text] [Related]
14. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
[TBL] [Abstract][Full Text] [Related]
15. A novel natural mutation AαPhe98Ile in the fibrinogen coiled-coil affects fibrinogen function.
Riedelová-Reicheltová Z; Kotlín R; Suttnar J; Geierová V; Riedel T; Májek P; Dyr JE
Thromb Haemost; 2014 Jan; 111(1):79-87. PubMed ID: 24108601
[TBL] [Abstract][Full Text] [Related]
16. Concepts of clot lysis.
Francis CW; Marder VJ
Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of disseminated intravascular coagulation.
Müller-Berghaus G; Hasegawa H
Bibl Haematol; 1983; (49):3-13. PubMed ID: 6667251
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen and Fibrin.
Litvinov RI; Pieters M; de Lange-Loots Z; Weisel JW
Subcell Biochem; 2021; 96():471-501. PubMed ID: 33252741
[TBL] [Abstract][Full Text] [Related]
19. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
Terasawa F; Kani S; Hongo M; Okumura N
Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498
[TBL] [Abstract][Full Text] [Related]
20. The role of thrombin in haemostasis.
Al-Amer OM
Blood Coagul Fibrinolysis; 2022 Apr; 33(3):145-148. PubMed ID: 35239615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
